
The Korean Fair Trade Commission (KFTC) Chairwoman Joh Sung-wook stressed that the Commission will not rule out adding foreigners to its chaebol “watch list,” following a controversial decision not to name Korean-American Kim Bom-suk, the founder and controlling shareholder of e-commerce giant Coupang, on its updated list, April 29.
Introduced in 1987, the watch list was mainly aimed at banning family members of big business conglomerates known as “chaebol” from awarding business contracts to affiliated companies and to prevent owners from using cross-shareholding and other practices to control their corporate empires despite holding a tiny stake.
“There should be an overhaul of the regulatory framework that can be more effectively implemented to control large business groups without discriminating against entrepreneurs due to their citizenship,” Joh said during a press conference at Government Complex Sejong, Tuesday, May 11.
This was the KFTC chief’s first meeting with reporters after it added Coupang to its new watch list, but not Kim due to his nationality.
The measure drew criticism that the KFTC lacks consistency and fairness in filing the list, considering that Korean entrepreneurs who were under a similar circumstance to Kim were targeted by the Commission.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas